 VALENCIA, Calif. and MELBOURNE, Australia, June 29, 2021 GLOBE NEWSWIRE -- AVITA Medical, Inc. NASDAQ: RCEL, ASX: AVH, a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, today announced that as part of the annual reconstitution of the Russell stock indexes, AVITA Medical has been added to the Russell 3000 Index effective June 28, 2021. 